Maverick Ventures is a venture capital firm based in San Francisco, California, founded in 2015. As the venture arm of Maverick Capital, it specializes in providing growth capital primarily in the healthcare, technology, and consumer sectors. In healthcare, the firm focuses on software and services, medical devices, tools and diagnostics, and biotechnology and pharmaceuticals. In the technology and consumer sectors, Maverick Ventures emphasizes investments in online, mobile, and offline-first companies. With a team that combines over 30 years of early-stage investment experience, Maverick Ventures has funded more than 100 companies and actively engages with entrepreneurs from seed funding through to maturation, often leading investment rounds and participating on boards to help build successful enterprises.
Nourish is a telehealth platform focused on enhancing health by facilitating access to evidence-based nutritional counseling. The company connects users with registered dietitians, who provide clinical-grade nutrition care through a virtual network. This approach allows individuals to receive personalized nutrition therapy, making it easier to maintain a healthy diet. Nourish's services are covered by health insurance, ensuring that users can access professional guidance without financial barriers. Through its platform, Nourish aims to support individuals in achieving their health and wellness goals.
Chapter
Series D in 2025
Chapter operates a Medicare navigation platform designed to assist seniors in selecting appropriate health coverage. The platform provides advisory services that ensure consumers receive the best coverage options tailored to their individual needs at the most affordable prices. By aligning the incentives of Medicare advisors and consumers, Chapter promotes unbiased recommendations that consider all available options, free from economic conflicts of interest. Additionally, the company offers retirees personalized resources such as tailored coupons, tax advice, and technology tips, enhancing their ability to live securely and purposefully as they age.
Daymark Health
Seed Round in 2025
Daymark Health is a value-based oncology company redefining the cancer care experience for patients, providers, and health plans.
AheadComputing
Seed Round in 2025
AheadComputing is a company that specializes in designing, licensing, and providing support for high-performance microprocessor cores and related technologies.
Aligned Marketplace
Seed Round in 2025
Aligned Marketplace operates as a personalized primary care for workforce.
Esperto Medical
Series A in 2024
Esperto Medical is a medical device company based in Irvine, California, focused on developing advanced wearable diagnostic tools for both hospital and remote patient monitoring. The company utilizes a proprietary technology called resonance sonomanometry, which employs acoustic stimulation to measure blood pressure continuously and noninvasively, eliminating the need for calibration. By offering round-the-clock monitoring capabilities, Esperto Medical aims to enhance patient care and accessibility, allowing individuals to track their vital signs conveniently from home or within clinical settings.
Terray Therapeutics
Series B in 2024
Terray Therapeutics is a biotechnology company based in Pasadena, California, founded in 2018. The company specializes in developing innovative treatments for complex human diseases by integrating experimentation and computation to enhance small molecule drug discovery. Terray's unique platform employs ultra-dense microarray technology alongside artificial intelligence and synthetic chemistry to generate extensive and precise chemical datasets. This allows for a rapid design-make-test-analyze cycle, facilitating efficient exploration of chemical space and mapping biochemical interactions between small molecules and disease causes. By utilizing automation and machine learning, Terray addresses significant therapeutic challenges, ultimately guiding the next cycles of drug design and experimentation.
TensorWave
Venture Round in 2024
TensorWave enables enterprises to harness the power of artificial intelligence and create innovative AI-based software.
Orasis Pharmaceuticals
Series D in 2024
Orasis Pharmaceuticals Ltd is focused on developing innovative treatments for presbyopia, a common age-related vision condition. Founded in 2015 and based in Herzliya, Israel, the company has developed CSF-1, a corrective eye drop designed to improve near visual acuity through pupil modulation. This product aims to enhance the quality of life for individuals with presbyopia by alleviating the need for reading glasses. CSF-1 repurposes existing, well-studied molecules to ensure its effectiveness while prioritizing safety, comfort, and ease of use for patients. By providing a noninvasive treatment option, Orasis Pharmaceuticals offers a promising solution for those struggling with the symptoms of presbyopia.
Spear Bio
Series A in 2024
Spear Bio is a biotechnology company established in 2021 and located in Weston, Massachusetts. The company specializes in ultrasensitive protein detection technology, which provides significant advantages in the healthcare sector. Its innovations support self-testing and telemedicine-based diagnostics by enabling the quantification of minute protein biomarkers from samples collected at home. This approach allows clinicians to achieve ultrasensitive detection using small sample volumes, seamlessly integrating into existing workflows for sample collection, processing, and analysis.
Daffodil Health
Seed Round in 2024
Daffodil Health is a pediatric behavioral health platform focused on supporting special needs children and their families. The company provides multi-modal therapies and real-time assistance tailored to the unique challenges faced by neurodiverse children. Its platform features a questionnaire designed for parents who observe developmental difficulties in their children. After analyzing the responses, Daffodil Health offers a free online consultation to discuss the concerns and develop an appropriate program. This approach empowers parents to actively participate in their child's therapeutic journey, equipping them with the tools and guidance needed to navigate the complexities of their child's needs.
Chapter
Series C in 2024
Chapter operates a Medicare navigation platform designed to assist seniors in selecting appropriate health coverage. The platform provides advisory services that ensure consumers receive the best coverage options tailored to their individual needs at the most affordable prices. By aligning the incentives of Medicare advisors and consumers, Chapter promotes unbiased recommendations that consider all available options, free from economic conflicts of interest. Additionally, the company offers retirees personalized resources such as tailored coupons, tax advice, and technology tips, enhancing their ability to live securely and purposefully as they age.
Thintronics
Series A in 2024
Thintronics is a Consumer Electronics company.
Clarity Pediatrics
Seed Round in 2024
Clarity Pediatrics is focused on transforming pediatric chronic care, particularly for children diagnosed with Attention-deficit/hyperactivity disorder (ADHD), which affects nearly 10% of American children. The company has developed a virtual pediatric ADHD clinic that utilizes a tech-enabled platform to deliver high-quality care to families. This platform includes features such as video conferencing, secure messaging, and electronic health records, allowing for accessible and efficient communication. Clarity Pediatrics aims to provide trusted care that is backed by scientific research, with the goal of achieving exceptional health outcomes that can significantly improve a child's developmental trajectory. By leveraging technology, the clinic seeks to reach a broader market of families, irrespective of their location or insurance status, ensuring that children receive the necessary support and resources.
Auradine
Series B in 2024
Auradine is a provider of web infrastructure solutions that focuses on blockchain, security, and privacy. The company offers a comprehensive range of services, including software, hardware, and cloud solutions designed to deliver scalable, sustainable, and secure infrastructure. With a strong background in security, software-as-a-service, semiconductors, and systems, Auradine aims to create innovative technologies that empower clients to adopt disruptive infrastructure. By integrating cutting-edge advancements in artificial intelligence, Auradine seeks to enhance its offerings and support businesses in navigating the evolving digital landscape.
SiMa.ai
Series C in 2024
SiMa.ai is a company based in San Jose, California, focused on designing and developing a machine learning platform that provides a single-chip solution for embedded systems. The company specializes in machine learning system-on-chip (MLSoC) technology, which allows for high-performance machine learning inference at low power in edge applications. SiMa.ai's platform enables seamless deployment and scaling of machine learning solutions, addressing various computer vision challenges with significantly improved performance and energy efficiency. The hardware-to-software stack of SiMa.ai is adaptable to multiple frameworks and models, enhancing the capabilities of applications in areas such as computer vision and generative AI. Founded in 2018, SiMa.ai aims to facilitate the integration of advanced machine learning technology into embedded systems while ensuring safe and secure operations.
Aligned Marketplace
Seed Round in 2024
Aligned Marketplace operates as a personalized primary care for workforce.
Nourish
Series A in 2024
Nourish is a telehealth platform focused on enhancing health by facilitating access to evidence-based nutritional counseling. The company connects users with registered dietitians, who provide clinical-grade nutrition care through a virtual network. This approach allows individuals to receive personalized nutrition therapy, making it easier to maintain a healthy diet. Nourish's services are covered by health insurance, ensuring that users can access professional guidance without financial barriers. Through its platform, Nourish aims to support individuals in achieving their health and wellness goals.
BlueFlag Security
Seed Round in 2024
BlueFlag Security provides a multi-layered defense platform that combines identity security, open-source software risk management, and developer tool posture management.
Oula Health
Series B in 2024
Oula Health, Inc. specializes in maternity care services, offering both in-clinic and home-based prenatal care. Founded in 2019 and located in Brooklyn, New York, Oula aims to transform the maternity care experience by integrating obstetrics and midwifery. The company focuses on providing a personalized and evidence-based approach to pregnancy, combining modern medical practices with a compassionate understanding of human needs. Through its innovative maternity center, Oula sets a new standard for pregnancy care that emphasizes both medical expertise and personal connection.
Areteia Therapeutics
Series A in 2024
Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.
Silicon Box
Series B in 2024
Silicon Box is an advanced provider of outsourced semiconductor assembly and testing services, focusing on semiconductor integration. The company offers comprehensive capabilities in semiconductor packaging, from initial design to the final manufacturing of various chip types, including standard single chip packages and sophisticated chiplet-based systems. Its services support a wide range of applications, such as artificial intelligence, high-performance computing, electric vehicles, automotive technologies, power management, and mobile chipsets. Silicon Box aims to enhance chipset design through its manufacturing processes, which help shorten design cycles, reduce costs, and lower power consumption, ultimately delivering advanced and high-quality semiconductor interconnections to its customers.
Devoted
Series E in 2023
Devoted Health is a healthcare company focused on enhancing the health and well-being of older Americans by treating each individual with care and compassion. The company offers an integrated healthcare solution that includes Medicare Advantage plans, access to local providers, and the option for virtual and in-home care through Devoted Medical. Their approach includes personalized medical plans and dedicated guides who work closely with physicians to streamline care and minimize unnecessary procedures. By leveraging advanced technology and a robust network of healthcare professionals, Devoted Health aims to provide high-quality, tailored healthcare services to its members.
Spear Bio
Seed Round in 2023
Spear Bio is a biotechnology company established in 2021 and located in Weston, Massachusetts. The company specializes in ultrasensitive protein detection technology, which provides significant advantages in the healthcare sector. Its innovations support self-testing and telemedicine-based diagnostics by enabling the quantification of minute protein biomarkers from samples collected at home. This approach allows clinicians to achieve ultrasensitive detection using small sample volumes, seamlessly integrating into existing workflows for sample collection, processing, and analysis.
Tenstorrent
Venture Round in 2023
Tenstorrent Inc. is a Canadian company that develops and manufactures application-specific integrated circuits (ASIC) focused on artificial intelligence and machine learning. Founded in 2016 and headquartered in Toronto, with an additional office in Austin, Texas, Tenstorrent specializes in providing scalable and efficient hardware solutions for various applications, ranging from battery-powered Internet of Things (IoT) devices to large cloud servers. The company’s architecture supports deep learning and enables adaptability in algorithms, catering to developers and researchers in the technology sector. By offering advanced AI hardware and software, Tenstorrent aims to enhance computational performance and facilitate the growth of machine learning technologies.
Gather Health
Series A in 2023
Gather Health is an international healthcare technology company dedicated to empowering patients with chronic diseases to enhance their health. The company specializes in mobile and cloud-based healthcare applications that utilize the latest medical and behavioral change research to motivate and educate patients. By connecting physicians, patients, their families, and patient communities, Gather Health aims to provide continuous and holistic care, ultimately improving health outcomes. The rise in chronic diseases, such as obesity and diabetes, has created a demand for better care, which Gather Health addresses by equipping patients and healthcare providers with effective tools for managing these conditions. Their flagship product, the Gather Health Diabetes platform, has been successfully implemented in cities including Mumbai, Ahmedabad, Hyderabad, Chennai, and Bangalore, showing positive health outcomes for patients and increased efficiency for healthcare providers. Headquartered in Hong Kong, with offices in Beijing, New York, and India, Gather Health's team comprises clinicians, health experts, interaction designers, and engineers experienced in global healthcare.
Zus Health
Series A in 2023
Zus Health is a healthcare technology company founded in 2020 in Watertown, Massachusetts, by Jonathan Bush. The company develops a healthcare data platform aimed at accelerating digital health initiatives. Its platform uniquely integrates health and non-health data, offering a comprehensive view of patients while facilitating the sharing of clinical and non-clinical information across different applications. This approach empowers healthcare professionals to create customized digital technologies and services that are more affordable and accessible, addressing the common barriers in the healthcare sector. Zus Health is focused on fostering innovation among a new generation of healthcare builders, striving to enhance the overall health experience.
Oops
Seed Round in 2022
Oops is a venture-backed startup founded in 2022 and based in Salt Lake City, Utah. The company provides an online platform that simplifies the process of returning products by offering doorstep services for packing, taping, labeling, and transporting items. By streamlining returns, Oops enables individuals to manage their returns conveniently from home, saving them time, effort, and resources.
Infleqtion
Series B in 2022
Infleqtion specializes in quantum technology, providing high-value information processing and solutions that enhance global communication security and efficiency. The company, with offices in the United States, United Kingdom, and Australia, leverages over 17 years of foundational research from ColdQuanta to deliver software-configured, quantum-enabled products that operate at the Edge. These products focus on critical applications such as positioning, navigation, timing, and resilient energy distribution, while also facilitating accelerated quantum computing. Infleqtion serves a diverse clientele, including commercial organizations and government entities, helping them to harness the power of quantum technology for innovation and development.
CareHarmony
Series A in 2022
CareHarmony, LLC, established in 2015 and based in Brentwood, Tennessee, specializes in whole-person care coordination services, focusing on Chronic Care Management. The company provides healthcare providers, including physician practices, Accountable Care Organizations (ACOs), and Independent Practice Associations (IPAs), with a comprehensive platform designed to enhance patient experience and clinical outcomes. CareHarmony's offerings include 24/7 patient access, mobile application support, customized patient care plans, secure file sharing, and streamlined billing assistance for Chronic Care Management. By integrating high-tech solutions with compassionate care, CareHarmony enables healthcare providers to adopt a limited-risk approach to value-based care.
Carta Healthcare
Series B in 2022
Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.
Areteia Therapeutics
Series A in 2022
Areteia Therapeutics is a biotechnology company focused on improving the management of eosinophilic asthma through an innovative oral drug treatment. The company, which emerged from Knopp, aims to provide patients with a novel therapeutic option that inhibits the maturation of eosinophils—cells that can cause airway damage in asthma patients. Its drug candidate has demonstrated promising results in a phase 2 clinical trial, which showed a reduction in blood eosinophil counts, indicating enhanced lung function. This approach seeks to empower patients by offering a potentially effective and accessible treatment for a severe form of asthma, thereby improving their quality of life and disease management.
Proximie
Series C in 2022
Proximie Inc. is a health technology company based in Bedford, Massachusetts, that specializes in a telehealth platform designed for virtual surgical assistance. Founded in 2016 by Nadine Hachach-Haram, Proximie's platform enables surgeons to remotely observe and guide complex surgical procedures using augmented reality, artificial intelligence, and machine learning. This technology allows expert surgeons to connect with their peers globally, sharing knowledge and skills in real-time, regardless of their physical location. The platform is adaptable, compatible with various devices and software used in operating rooms, and can function effectively even in low bandwidth environments. Proximie aims to enhance surgical practices by democratizing access to expert guidance and fostering collaboration among medical professionals.
Coherent
Series B in 2022
Coherent is a technology company that specializes in providing software solutions for the insurance industry. Founded in 2018 and headquartered in Causeway Bay, Hong Kong, with additional offices in Shanghai, Singapore, and Manila, Coherent develops applications that enhance product development, sales, and customer engagement for insurance companies. Its flagship offerings include Factory, a tool enabling insurers to digitize backend operations and manage pricing models through Excel; Coherent Connect, a social media marketing campaign manager; Coherent Explainer, which simplifies the quote breakdown process; and Coherent Flow, designed for remote policy sales through features like video chat and electronic signatures. Additionally, the company offers Coherent Spark, a no-code platform that transforms spreadsheet-based business logic into customized APIs, facilitating better integration of software solutions across business operations.
D-ID
Series B in 2022
D-ID is a software development company specializing in face recognition technologies and artificial intelligence solutions. Founded in 2016 and headquartered in Palo Alto, California, with an additional office in Tel Aviv, Israel, D-ID provides a range of products including de-identification software that enhances identity theft protection and ensures compliance with regulations by removing sensitive biometric data from facial images. The company also offers API, reality studio, and portrait products that utilize AI to create talking avatars and videos, catering to sectors such as marketing, e-learning, corporate training, and content creation. D-ID's technology aims to facilitate seamless interactions through natural conversation and to enhance user experiences across various applications.
PrognomIQ
Venture Round in 2022
PrognomiQ is a technology company dedicated to advancing early disease detection and treatment, particularly for cancer and other complex diseases. By harnessing multi-omics data, including proteomic, genomic, and metabolomic information, the company aims to enhance understanding and management of health conditions. PrognomiQ's innovative approach allows for the development of advanced medical test products that improve diagnostic capabilities and recurrence monitoring, ultimately seeking to enhance patient outcomes. Through its focus on integrating diverse health data, PrognomiQ is committed to transforming how medical practitioners approach disease detection and treatment.
Volta Labs
Series A in 2022
Volta Labs, Inc. is a biotechnology company based in Cambridge, Massachusetts, founded in 2018. The company specializes in developing tools for biological automation, focusing on scalable automation solutions for genetic engineering. Volta Labs operates a platform designed for affordable genomic sample preparation, aimed at revolutionizing genomics research. This platform leverages automation and miniaturization technologies to streamline the creation of biological samples. By integrating expertise from engineering, surface chemistry, and molecular biology, Volta Labs enables biotech organizations to automate complex biological workflows, facilitating advancements in genomics and genetic engineering.
FitOn
Series C in 2022
FitOn Inc. is a fitness technology company based in Los Angeles, California, established in 2018. It has developed a fitness application that allows users to participate in live and on-demand workout classes without the need for equipment. The app offers a diverse range of classes, including yoga, Pilates, pre and post-natal workouts, interval training, cardio, dance, and barre, all led by world-class trainers and celebrities. FitOn’s platform has attracted over 12 million members who have collectively logged more than one billion workout minutes. Additionally, the company provides FitOn Health, an enterprise service that partners with over 13,000 employers and major health plans in the United States to offer expert-led programs aimed at individuals managing chronic conditions. The application also features tools for calorie tracking, monitoring heart rates, and sharing progress with friends, enhancing the overall fitness experience.
Lusix
Private Equity Round in 2022
Lusix is a manufacturer of lab-grown diamonds, focusing on providing affordable luxury to consumers who are environmentally and socially conscious. The company utilizes proprietary technology and scientific expertise to cultivate high-yield diamonds that exhibit exceptional quality and color. By producing diamonds that are ethically sourced and environmentally friendly, Lusix aims to supply the gemstone market and various industrial applications, catering to a growing demand for sustainable alternatives in the jewelry sector.
Dewpoint Therapeutics
Series C in 2022
Dewpoint Therapeutics is a Boston-based biotech company focused on the research and development of treatments targeting biomolecular condensates to address various diseases, including cancer, neurodegenerative disorders, and immunological conditions. Founded in 2018, the company employs an innovative drug platform that utilizes machine-learning-based image analysis for visualizing condensates. This technology supports an engine of engineered cell lines designed to track and mitigate harmful protein sequestration. By leveraging its proprietary platform, Dewpoint seeks to facilitate drug discovery across a wide range of medical indications and collaborates with leading academic and pharmaceutical partners to enhance the accessibility of new therapies for unmet healthcare needs.
Clari
Series F in 2022
Clari Inc. is a revenue operations platform based in Sunnyvale, California, founded in 2012. The company utilizes automation and artificial intelligence to consolidate and analyze activity data from various business systems, such as CRM, email, calendar, and marketing automation. This integration provides sales professionals with improved visibility into their deals and relationships, enabling them to close deals more efficiently and reduce manual reporting efforts. Clari's platform offers features like Activity Analytics, which delivers predictive insights and real-time data analysis, allowing sales teams and managers to optimize their strategies, enhance coaching, and effectively allocate resources. By streamlining revenue operations, Clari assists B2B companies, including notable clients like Qualtrics and Adobe, in forecasting business performance, managing pipelines, and minimizing customer churn.
Chapter
Series B in 2022
Chapter operates a Medicare navigation platform designed to assist seniors in selecting appropriate health coverage. The platform provides advisory services that ensure consumers receive the best coverage options tailored to their individual needs at the most affordable prices. By aligning the incentives of Medicare advisors and consumers, Chapter promotes unbiased recommendations that consider all available options, free from economic conflicts of interest. Additionally, the company offers retirees personalized resources such as tailored coupons, tax advice, and technology tips, enhancing their ability to live securely and purposefully as they age.
Belong Health
Series A in 2021
Belong Health is a health insurance company focused on delivering Medicare Advantage and special needs plan products. The company collaborates with local health plans to provide regionally informed and compassionate care to a growing community. By partnering with these regional health plans, Belong Health aims to create a straightforward Medicare experience for eligible members, facilitating access to quality healthcare through trusted insurance partners. This approach allows Belong Health to launch or enhance market-leading plans that address the specific needs of its members.
Heap
Series D in 2021
Heap Inc. is a company that develops an analytics infrastructure designed for online businesses, enabling them to capture and analyze customer interactions across web, mobile, and cloud platforms. Founded in 2012 and headquartered in San Francisco, California, Heap's solution automates the collection and organization of customer behavioral data, such as clicks, transactions, and form submissions, without requiring additional coding. This streamlined approach allows businesses to gain a comprehensive understanding of their users, facilitating informed decision-making and enhancing product development. Heap serves a diverse range of industries, including e-commerce, financial services, and SaaS, with over 6,000 clients that include notable companies across various sectors. The company is committed to empowering organizations to focus on insights and actions that drive business success.
Conveyor
Seed Round in 2021
Conveyor is a leading platform that utilizes generative AI to streamline and automate customer security reviews, addressing a significant pain point in the sales process. By providing an end-to-end solution that includes a customer-facing trust portal, a GPT-powered tool for responding to questionnaires, and a comprehensive service for questionnaire completion, Conveyor enables vendors to enhance trust with their customers. This innovative approach significantly reduces the time spent on the tedious task of sharing security information and answering security questionnaires by over 90%. Trusted by top SaaS companies, Conveyor aims to simplify the security review process, allowing information security teams to focus on more strategic tasks.
FitOn
Series B in 2021
FitOn Inc. is a fitness technology company based in Los Angeles, California, established in 2018. It has developed a fitness application that allows users to participate in live and on-demand workout classes without the need for equipment. The app offers a diverse range of classes, including yoga, Pilates, pre and post-natal workouts, interval training, cardio, dance, and barre, all led by world-class trainers and celebrities. FitOn’s platform has attracted over 12 million members who have collectively logged more than one billion workout minutes. Additionally, the company provides FitOn Health, an enterprise service that partners with over 13,000 employers and major health plans in the United States to offer expert-led programs aimed at individuals managing chronic conditions. The application also features tools for calorie tracking, monitoring heart rates, and sharing progress with friends, enhancing the overall fitness experience.
Devoted
Series D in 2021
Devoted Health is a healthcare company focused on enhancing the health and well-being of older Americans by treating each individual with care and compassion. The company offers an integrated healthcare solution that includes Medicare Advantage plans, access to local providers, and the option for virtual and in-home care through Devoted Medical. Their approach includes personalized medical plans and dedicated guides who work closely with physicians to streamline care and minimize unnecessary procedures. By leveraging advanced technology and a robust network of healthcare professionals, Devoted Health aims to provide high-quality, tailored healthcare services to its members.
Centivo
Venture Round in 2021
Centivo Corporation is a health insurance provider that specializes in offering innovative health plans for self-funded employers, employees, and clinicians. Established in 2016 and headquartered in Stamford, Connecticut, with additional offices in New York and Buffalo, Centivo serves as an alternative to traditional insurance carriers and third-party administrators. The company integrates technology, network management, claims processing, and customer support to effectively administer health benefits. Centivo emphasizes collaboration between employees and their primary care teams to coordinate healthcare needs, encouraging members to engage in high-value care through personalized matching tools and a user-friendly app. By focusing on controlling costs and improving navigation through the healthcare system, Centivo positions itself as a dedicated partner to employers, ensuring accountability and minimizing waste in healthcare spending.
Chapter
Series A in 2021
Chapter operates a Medicare navigation platform designed to assist seniors in selecting appropriate health coverage. The platform provides advisory services that ensure consumers receive the best coverage options tailored to their individual needs at the most affordable prices. By aligning the incentives of Medicare advisors and consumers, Chapter promotes unbiased recommendations that consider all available options, free from economic conflicts of interest. Additionally, the company offers retirees personalized resources such as tailored coupons, tax advice, and technology tips, enhancing their ability to live securely and purposefully as they age.
Apna
Series C in 2021
Apna is India's largest professional networking platform, established in 2019, aimed at facilitating employment for the grey and blue-collar workforce. The platform serves over 35 million users across 75 cities in India, connecting them with more than 2 million employers. Users can create profiles, engage with peers, and schedule job interviews, all while accessing skilling opportunities to enhance their professional growth. By enabling job seekers to find employment that aligns with their skills and requirements, Apna also helps employers reduce hiring costs. The company has raised over $190 million from notable investors, underscoring its commitment to unlocking unique job opportunities and improving livelihoods for millions in India.
House Rx
Seed Round in 2021
House Rx is a health technology platform focused on improving affordability and patient access to specialty medications.
CCC Intelligent Solutions
Post in 2021
CCC Intelligent Solutions is a provider of cloud-based software and technology solutions tailored for the property and casualty insurance sector. Its platform connects over 30,000 businesses, including insurers, repairers, automakers, and part suppliers, by facilitating digital workflows and commerce. CCC specializes in leveraging artificial intelligence, telematics, and hyperscale technologies to enhance customer experiences and streamline operations. The company generates revenue primarily through software subscriptions and professional services and has a significant presence in the United States, with additional operations in China. By delivering innovative solutions, CCC plays a crucial role in digitizing mission-critical processes within the insurance industry.
Zus Health
Series A in 2021
Zus Health is a healthcare technology company founded in 2020 in Watertown, Massachusetts, by Jonathan Bush. The company develops a healthcare data platform aimed at accelerating digital health initiatives. Its platform uniquely integrates health and non-health data, offering a comprehensive view of patients while facilitating the sharing of clinical and non-clinical information across different applications. This approach empowers healthcare professionals to create customized digital technologies and services that are more affordable and accessible, addressing the common barriers in the healthcare sector. Zus Health is focused on fostering innovation among a new generation of healthcare builders, striving to enhance the overall health experience.
Fractyl Health
Series F in 2021
Fractyl Health, based in Lexington, Massachusetts, specializes in developing innovative medical device solutions for metabolic diseases, particularly type 2 diabetes and obesity. The company’s primary offering, Revita DMR, is a minimally invasive therapy that utilizes hydrothermal ablation to rejuvenate the duodenal lining, which can become compromised due to high-fat and high-sugar diets. By focusing on durable disease-modifying therapies rather than just symptomatic management, Fractyl Health aims to address the underlying causes of metabolic diseases, improving patient outcomes and reducing healthcare burdens. Founded in 2010 and originally named MedCatalyst, Inc., the company envisions a future where less invasive, device-based therapies provide effective solutions for large populations affected by metabolic disorders.
Belong Health
Seed Round in 2021
Belong Health is a health insurance company focused on delivering Medicare Advantage and special needs plan products. The company collaborates with local health plans to provide regionally informed and compassionate care to a growing community. By partnering with these regional health plans, Belong Health aims to create a straightforward Medicare experience for eligible members, facilitating access to quality healthcare through trusted insurance partners. This approach allows Belong Health to launch or enhance market-leading plans that address the specific needs of its members.
CareMax
Post in 2021
CareMax is a technology-enabled care platform focused on delivering value-based care and chronic disease management for seniors. The company operates a network of medical centers that provide a wide range of healthcare and social services. Additionally, CareMax has developed a proprietary software and services platform that offers data, analytics, and rules-based decision tools to assist physicians in their practice. This integrated approach aims to enhance the quality of care for seniors while managing their healthcare needs effectively across the United States.
Cano Health
Post in 2021
Cano Health is a healthcare company focused on providing personalized, value-based primary care services primarily for seniors. Operating across Florida, Texas, Nevada, and Puerto Rico, Cano Health manages primary care centers and supports affiliated medical practices. The company emphasizes high-touch population health management through a comprehensive care coordination strategy that includes wellness activities, pharmacy services, home visits, telehealth, and management of high-risk and complex cases. Serving approximately 310,000 members, Cano Health aims to enhance health outcomes, wellness, and quality of life for its patients and the communities it operates in.
QuintoAndar
Series E in 2021
QuintoAndar is a digital platform that streamlines the rental process for residential real estate in Brazil, catering to both landlords and renters. Founded in February 2013 by Gabriel Braga and Andre Penha, the company is headquartered in São Paulo. QuintoAndar offers a marketplace featuring various rental listings, allowing users to schedule visits and finalize agreements without the burden of paperwork. The platform also provides rental insurance and facilitates recurring payments, eliminating the need for guarantors. By prioritizing transparency and efficiency, QuintoAndar aims to enhance the rental experience for all parties involved.
Mon Ami
Seed Round in 2021
Mon Ami, Inc. is a California-based company founded in 2018 that has developed an application aimed at connecting college students with seniors who experience social isolation due to conditions such as dementia, Alzheimer’s, Parkinson’s disease, autism, and cancer. The platform facilitates meetings between seniors and companions or families, addressing the growing need for social connectivity among older adults. Additionally, Mon Ami offers software solutions tailored for aging and disability service providers, allowing them to enhance their operational efficiency and reduce administrative burdens. These tools are designed to be HIPAA compliant, enabling service providers to streamline workflows, increase their capacity to assist more seniors, and effectively track outcomes related to senior well-being. Through these initiatives, Mon Ami seeks to address challenges in the senior services market and improve the quality of life for older adults.
SnapDocs
Series D in 2021
Snapdocs, Inc. is a real estate technology firm based in San Francisco that specializes in creating a digital platform for mortgage closings. Founded in 2013, Snapdocs connects lenders, title companies, and notary signing agents to enhance the efficiency and accuracy of the closing process. The platform automates interactions and workflows, allowing for streamlined operations and improved customer experiences. It offers features that enable lenders to adopt digital closings, providing flexibility in closing types, while also allowing title and escrow clients to automate their workflows. Notary signing agents can showcase their qualifications, and home buyers gain early access to their closing packages, fostering a smoother transaction. By leveraging advanced automation and AI technology, Snapdocs aims to simplify the complexities of mortgage closings, ultimately saving time and reducing costs for all participants involved.
Infleqtion
Convertible Note in 2021
Infleqtion specializes in quantum technology, providing high-value information processing and solutions that enhance global communication security and efficiency. The company, with offices in the United States, United Kingdom, and Australia, leverages over 17 years of foundational research from ColdQuanta to deliver software-configured, quantum-enabled products that operate at the Edge. These products focus on critical applications such as positioning, navigation, timing, and resilient energy distribution, while also facilitating accelerated quantum computing. Infleqtion serves a diverse clientele, including commercial organizations and government entities, helping them to harness the power of quantum technology for innovation and development.
Collective Health
Series F in 2021
Collective Health is a prominent health benefits platform that streamlines the management of medical, dental, vision, and pharmacy services for employees and their families. By offering an integrated solution through a cloud-based self-insurance platform, the company simplifies the administration of health plans via a single portal. This platform provides users with clear guidance, live concierge support, and digital tools to facilitate the navigation and management of healthcare services. Collective Health aims to reduce the complexities of delivering health benefits, enhance the member experience, and promote healthier outcomes for both employees and organizations. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.
Proximie
Series B in 2021
Proximie Inc. is a health technology company based in Bedford, Massachusetts, that specializes in a telehealth platform designed for virtual surgical assistance. Founded in 2016 by Nadine Hachach-Haram, Proximie's platform enables surgeons to remotely observe and guide complex surgical procedures using augmented reality, artificial intelligence, and machine learning. This technology allows expert surgeons to connect with their peers globally, sharing knowledge and skills in real-time, regardless of their physical location. The platform is adaptable, compatible with various devices and software used in operating rooms, and can function effectively even in low bandwidth environments. Proximie aims to enhance surgical practices by democratizing access to expert guidance and fostering collaboration among medical professionals.
Carta Healthcare
Series A in 2021
Carta Healthcare, Inc. is a technology company that specializes in developing a software-as-a-service platform aimed at improving hospital patient management. Founded in 2016 and headquartered in San Mateo, California, the company leverages data from existing IT systems to map the patient journey through hospitals. Its platform utilizes machine learning to identify similarities between current patients and past patients, allowing healthcare providers to personalize care based on individual needs. Additionally, it predicts potential bottlenecks, such as recovery bed shortages and cancellations, offering alerts that help hospitals optimize their operations. By combining artificial intelligence with human expertise, Carta Healthcare enhances the efficiency and quality of healthcare data management, ultimately aiming to provide a better experience for patients.
KUDO
Series A in 2021
KUDO, Inc., also known as Kudo Technologies, specializes in a language as a service (LaaS) platform designed for multilingual online meetings. Founded in 2016 and headquartered in New York, KUDO provides a cloud-based software as a service (SaaS) that facilitates video conferencing and chatting with integrated support for interpreters and multiple audio streams. The platform enables businesses to conduct multilingual live events and offers tools for web conferencing and language-ready rooms. KUDO's solutions allow teams to communicate effectively across global markets, ensuring that participants and interpreters can connect from anywhere using standard computers or smartphones.
Cityblock
Series C in 2021
Cityblock Health is a technology-driven provider focused on meeting the complex health and social needs of Medicaid and Medicare populations. The company delivers a personalized health system that integrates primary care, behavioral health, and social services, partnering with community-based organizations to ensure tailored support for each member. By investing in prevention-oriented care and utilizing technology to enhance coordination and communication, Cityblock aims to improve health outcomes while reducing costs. During the COVID-19 pandemic, the organization developed a model to identify members at high risk, demonstrating its commitment to addressing urgent health challenges within communities.
Cylera
Series A in 2021
Cylera, Inc. is a cybersecurity company focused on protecting healthcare organizations from cyber threats and malware. Founded in 2017 and headquartered in New York, Cylera offers a comprehensive platform that utilizes patented technology to provide unified cybersecurity solutions. Their software specializes in asset management, risk analysis, and threat detection, specifically designed for the healthcare Internet of Things (IoT) environment. By identifying all connected devices, analyzing vulnerabilities, and mitigating threats in real time, Cylera enables healthcare providers and other organizations to effectively manage risks and respond automatically to potential security incidents.
Caribou Biosciences
Series C in 2021
Caribou Biosciences, Inc. is a biotechnology company based in Berkeley, California, that specializes in cellular engineering and genome editing solutions using CRISPR technology. Incorporated in 2011, the company has developed a CRISPR-Cas gene editing platform that allows precise modifications to DNA, which is applicable across various fields including human and animal therapeutics, agricultural biotechnology, and industrial biotech. Caribou's innovative approach aims to create transformative therapies, particularly in the development of allogeneic CAR-T and CAR-NK cell therapies, targeting serious diseases. The company focuses on advancing its pipeline of next-generation genome-edited cell therapies while also contributing to basic and applied biological research.
Garner Health
Series A in 2021
Garner Health is a technology company established in 2019 and based in New York, NY, that focuses on enhancing the healthcare experience for employees through employer partnerships. By leveraging a doctor quality analytics platform, Garner Health provides insights into clinical quality and total care costs, helping employers direct their employees to high-quality healthcare providers. The platform also offers an overlay account that covers employee deductibles and coinsurance, allowing employees to reduce out-of-pocket expenses while ensuring employers achieve guaranteed savings. Through this approach, Garner Health aims to improve healthcare quality and affordability for both employees and their employers.
Cityblock
Series C in 2020
Cityblock Health is a technology-driven provider focused on meeting the complex health and social needs of Medicaid and Medicare populations. The company delivers a personalized health system that integrates primary care, behavioral health, and social services, partnering with community-based organizations to ensure tailored support for each member. By investing in prevention-oriented care and utilizing technology to enhance coordination and communication, Cityblock aims to improve health outcomes while reducing costs. During the COVID-19 pandemic, the organization developed a model to identify members at high risk, demonstrating its commitment to addressing urgent health challenges within communities.
Centivo
Series B in 2020
Centivo Corporation is a health insurance provider that specializes in offering innovative health plans for self-funded employers, employees, and clinicians. Established in 2016 and headquartered in Stamford, Connecticut, with additional offices in New York and Buffalo, Centivo serves as an alternative to traditional insurance carriers and third-party administrators. The company integrates technology, network management, claims processing, and customer support to effectively administer health benefits. Centivo emphasizes collaboration between employees and their primary care teams to coordinate healthcare needs, encouraging members to engage in high-value care through personalized matching tools and a user-friendly app. By focusing on controlling costs and improving navigation through the healthcare system, Centivo positions itself as a dedicated partner to employers, ensuring accountability and minimizing waste in healthcare spending.
Infleqtion
Series A in 2020
Infleqtion specializes in quantum technology, providing high-value information processing and solutions that enhance global communication security and efficiency. The company, with offices in the United States, United Kingdom, and Australia, leverages over 17 years of foundational research from ColdQuanta to deliver software-configured, quantum-enabled products that operate at the Edge. These products focus on critical applications such as positioning, navigation, timing, and resilient energy distribution, while also facilitating accelerated quantum computing. Infleqtion serves a diverse clientele, including commercial organizations and government entities, helping them to harness the power of quantum technology for innovation and development.
Dewpoint Therapeutics
Series B in 2020
Dewpoint Therapeutics is a Boston-based biotech company focused on the research and development of treatments targeting biomolecular condensates to address various diseases, including cancer, neurodegenerative disorders, and immunological conditions. Founded in 2018, the company employs an innovative drug platform that utilizes machine-learning-based image analysis for visualizing condensates. This technology supports an engine of engineered cell lines designed to track and mitigate harmful protein sequestration. By leveraging its proprietary platform, Dewpoint seeks to facilitate drug discovery across a wide range of medical indications and collaborates with leading academic and pharmaceutical partners to enhance the accessibility of new therapies for unmet healthcare needs.
Galecto
Series D in 2020
Galecto is a clinical-stage biotechnology company focused on developing small-molecule therapeutics to address severe diseases, particularly fibrosis and cancer. Established in 2011, Galecto builds on over a decade of research into the roles of galectin-3 and lysyl oxidase-like 2 (LOXL2) in fibrotic diseases. The company's lead product candidate, GB0139, is an inhaled galectin-3 inhibitor specifically designed for treating severe fibrotic lung diseases, such as idiopathic pulmonary fibrosis (IPF), where there is a significant unmet medical need. Additionally, Galecto is advancing GB1211, an oral selective galectin-3 inhibitor aimed at addressing fibrosis related to non-alcoholic steatohepatitis. With a robust patent portfolio, Galecto leverages its unique therapeutic platform to target the underlying biological processes associated with fibrosis and related diseases.
PrognomIQ
Venture Round in 2020
PrognomiQ is a technology company dedicated to advancing early disease detection and treatment, particularly for cancer and other complex diseases. By harnessing multi-omics data, including proteomic, genomic, and metabolomic information, the company aims to enhance understanding and management of health conditions. PrognomiQ's innovative approach allows for the development of advanced medical test products that improve diagnostic capabilities and recurrence monitoring, ultimately seeking to enhance patient outcomes. Through its focus on integrating diverse health data, PrognomiQ is committed to transforming how medical practitioners approach disease detection and treatment.
Orasis Pharmaceuticals
Series C in 2020
Orasis Pharmaceuticals Ltd is focused on developing innovative treatments for presbyopia, a common age-related vision condition. Founded in 2015 and based in Herzliya, Israel, the company has developed CSF-1, a corrective eye drop designed to improve near visual acuity through pupil modulation. This product aims to enhance the quality of life for individuals with presbyopia by alleviating the need for reading glasses. CSF-1 repurposes existing, well-studied molecules to ensure its effectiveness while prioritizing safety, comfort, and ease of use for patients. By providing a noninvasive treatment option, Orasis Pharmaceuticals offers a promising solution for those struggling with the symptoms of presbyopia.
Decent
Series A in 2020
Decent Inc. is a company that specializes in providing health and medical insurance plans tailored for self-employed professionals. Founded in 2018 and based in Mill Valley, California, Decent offers plans such as the Trailblazer Plan, which is designed to meet the comprehensive health needs of freelance workers. The company focuses on delivering more affordable healthcare by aligning incentives that promote better health outcomes, reduce overall costs, and prioritize the needs of its members in the healthcare process.
Octopai
Series A in 2020
Octopai is an Automated Data Intelligence platform that assists data teams in managing complex data landscapes. The platform provides multilayered data lineage, data discovery, and a comprehensive data catalog, facilitating the tracking of data assets and understanding of data flow within organizations. By offering a no-code solution, Octopai helps businesses streamline their data operations, allowing for easier access to vital information and the ability to trust their data resources. This approach effectively addresses organizational data challenges and enhances overall data management efficiency.
Seer
Series D in 2020
Seer, Inc. is a life sciences company that specializes in nanoparticle technology solutions aimed at advancing proteomics research. The company offers Proteograph, an integrated system that includes consumables, automation instrumentation, and proprietary software for conducting proteomics analysis. Seer's products are designed for research applications, targeting academic institutions, life sciences laboratories, and biopharmaceutical companies for non-diagnostic and non-clinical uses. Additionally, Seer is focused on developing a health data platform that enhances early detection of chronic diseases by capturing and translating molecular insights from the proteome, thereby enabling healthcare professionals to identify conditions such as cancer and neurological disorders more accurately and rapidly. Founded in 2017 and headquartered in Redwood City, California, Seer was previously known as Seer Biosciences, Inc. before rebranding in July 2018.
Cityblock
Series B in 2020
Cityblock Health is a technology-driven provider focused on meeting the complex health and social needs of Medicaid and Medicare populations. The company delivers a personalized health system that integrates primary care, behavioral health, and social services, partnering with community-based organizations to ensure tailored support for each member. By investing in prevention-oriented care and utilizing technology to enhance coordination and communication, Cityblock aims to improve health outcomes while reducing costs. During the COVID-19 pandemic, the organization developed a model to identify members at high risk, demonstrating its commitment to addressing urgent health challenges within communities.
Behalf
Series D in 2020
Behalf, Inc. is a financing provider headquartered in New York, with an additional office in Tel Aviv, Israel. Founded in 2011, the company facilitates commerce between B2B merchants and their business customers by offering automated payment solutions that include instant credit and flexible payment terms at the point of sale. Behalf integrates seamlessly into merchants' sales and invoicing processes, allowing for access to financing regardless of the invoice or transaction size. By paying merchants upfront, Behalf enhances sales and improves cash flow for both merchants and their business customers. The company focuses on providing short-term financing to small businesses, enabling them to efficiently manage payments to suppliers while increasing operational effectiveness through automation.
D-ID
Series A in 2020
D-ID is a software development company specializing in face recognition technologies and artificial intelligence solutions. Founded in 2016 and headquartered in Palo Alto, California, with an additional office in Tel Aviv, Israel, D-ID provides a range of products including de-identification software that enhances identity theft protection and ensures compliance with regulations by removing sensitive biometric data from facial images. The company also offers API, reality studio, and portrait products that utilize AI to create talking avatars and videos, catering to sectors such as marketing, e-learning, corporate training, and content creation. D-ID's technology aims to facilitate seamless interactions through natural conversation and to enhance user experiences across various applications.
BioCatch
Series C in 2020
BioCatch is a pioneering company specializing in behavioral biometrics, which focuses on analyzing the digital behavior of online users to enhance fraud detection and prevention. By leveraging advanced cognitive science and machine learning, BioCatch provides insights that help financial institutions identify potential risks associated with user interactions while maintaining privacy. The company's technology is designed to combat increasingly sophisticated fraud tactics, including social engineering scams, and to streamline the digital banking experience from account creation to login and beyond. With over a decade of experience and a robust portfolio of patents, BioCatch is committed to driving innovation in the field of digital security, enabling clients to effectively combat fraud while fostering a trusted online environment.
Revuze
Series A in 2020
Revuze specializes in Generative AI analysis of online reviews, transforming how businesses gather consumer insights. The company provides cloud-based software that automates the analysis of customer reviews and unstructured data, allowing clients to derive valuable insights into customer experiences and competitive positioning. Its solutions facilitate the integration of review analytics into marketing and product strategies, supporting informed decision-making. Revuze offers real-time analysis through user-friendly features such as dynamic dashboards and comprehensive reports, enabling businesses to navigate the evolving market landscape effectively. By leveraging high-quality data and insightful predictions, Revuze helps organizations understand their customers and competitors more deeply, ensuring they can make data-driven decisions with confidence.
ConcertAI
Series B in 2020
ConcertAI is a Boston-based company that develops a suite of medical research tools focused on oncology. Established in 2018, the company specializes in care-based oncology research and data analytics. Its solutions leverage integrated real-world data and artificial intelligence to enhance the generation of insights and expedite the delivery of therapeutic innovations to patients. By utilizing custom patient surveys, ConcertAI aids pharmaceutical companies in evaluating existing treatments and formulating new ones. This approach supports project teams, medical experts, and scientists in producing real-world evidence and insights to improve health outcomes and streamline clinical trial efficiency.
Bounce
Series D in 2020
Bounce (formerly known as Metro Bikes) is a smart mobility solution, with a mission of making daily commute stress-free, time-saving, reliable, and convenient. With a breakthrough technology that lets users access the bike with just an OTP, the Keyless bikes, have not only done away with keys, but the whole process of renting a bike has just become devoid of any physical or human intervention. With Bounce's new One Way Rental service, users can now pick up and drop the bike anywhere they need to and be done with the ride. This is aimed at providing a seamless first mile and last-mile connectivity to metro users. Founded in 2014, Bounce aims at decongesting the roads by encouraging commuters to choose public transport by delivering convenient options to rent bikes and reach their destinations from metro stations. It is based in Bangalore, India.
Seer
Series D in 2019
Seer, Inc. is a life sciences company that specializes in nanoparticle technology solutions aimed at advancing proteomics research. The company offers Proteograph, an integrated system that includes consumables, automation instrumentation, and proprietary software for conducting proteomics analysis. Seer's products are designed for research applications, targeting academic institutions, life sciences laboratories, and biopharmaceutical companies for non-diagnostic and non-clinical uses. Additionally, Seer is focused on developing a health data platform that enhances early detection of chronic diseases by capturing and translating molecular insights from the proteome, thereby enabling healthcare professionals to identify conditions such as cancer and neurological disorders more accurately and rapidly. Founded in 2017 and headquartered in Redwood City, California, Seer was previously known as Seer Biosciences, Inc. before rebranding in July 2018.
Infleqtion
Seed Round in 2019
Infleqtion specializes in quantum technology, providing high-value information processing and solutions that enhance global communication security and efficiency. The company, with offices in the United States, United Kingdom, and Australia, leverages over 17 years of foundational research from ColdQuanta to deliver software-configured, quantum-enabled products that operate at the Edge. These products focus on critical applications such as positioning, navigation, timing, and resilient energy distribution, while also facilitating accelerated quantum computing. Infleqtion serves a diverse clientele, including commercial organizations and government entities, helping them to harness the power of quantum technology for innovation and development.
Remrise
Seed Round in 2019
Remrise, Inc. is a health and wellness company focused on enhancing sleep through personalized, plant-based supplements. Founded in 2018 and based in San Francisco, Remrise offers a unique approach by utilizing a quiz to identify individual sleep issues, allowing for the creation of customized formulas. These formulas are composed of drug-free ingredients, including Reishi, Spine Date Seed, and L-Theanine, which aim to improve sleep cycles without causing grogginess. In addition to its personalized supplements, Remrise provides a digital platform for users to track their sleep and wellness progress, fostering a holistic approach to better sleep habits and overall health.
Bungalow
Series B in 2019
Bungalow is a residential real estate platform that facilitates flexible and communal living arrangements for renters, particularly targeting early career professionals. Founded in 2016 by Andrew Collins and Justin McCarty, the company is headquartered in San Francisco, California. Bungalow signs long-term leases with homeowners to offer multi-bedroom homes in desirable urban neighborhoods across the United States. Each property features private bedrooms with handpicked housemates, and comes fully furnished with essential amenities such as Wi-Fi, utilities, and housekeeping. Additionally, Bungalow organizes monthly community events to foster social interaction among residents. By addressing the needs of modern renters, Bungalow provides a convenient solution for those seeking quality living environments while cultivating a sense of community.
HumanFirst
Seed Round in 2019
HumanFirst is a developer of an AI-powered software-as-a-service platform that aims to enhance patient-centered clinical trials through the use of precision digital measures, including digital biomarkers and electronic clinical outcome assessments. The platform, recognized as the largest of its kind, provides biopharma companies with valuable insights and validated evidence data to streamline drug development processes. By facilitating the integration of digital health technologies, HumanFirst supports pharmaceutical organizations in improving research efficiency and accelerating the deployment of innovative treatments. The platform has been utilized by 22 of the 25 largest pharmaceutical companies worldwide, underscoring its significance in advancing human-centric research and development.
Science Exchange
Debt Financing in 2019
Science Exchange, Inc. operates an online marketplace that facilitates collaboration between researchers and scientific service providers, including academic and government laboratories. Founded in 2011 and based in Palo Alto, California, the company enables users to search for, compare, and procure scientific services from U.S. research institutions, streamlining the process of obtaining quotes, managing projects, and processing payments. The platform enhances research and development productivity by automating various collaborative tasks while ensuring data security and regulatory compliance. By matching researchers seeking to outsource experiments with qualified service providers, Science Exchange makes it easier and more affordable for scientific institutions and researchers to access outsourced research and development services, ultimately accelerating the pace of scientific discovery.
Science Exchange
Venture Round in 2019
Science Exchange, Inc. operates an online marketplace that facilitates collaboration between researchers and scientific service providers, including academic and government laboratories. Founded in 2011 and based in Palo Alto, California, the company enables users to search for, compare, and procure scientific services from U.S. research institutions, streamlining the process of obtaining quotes, managing projects, and processing payments. The platform enhances research and development productivity by automating various collaborative tasks while ensuring data security and regulatory compliance. By matching researchers seeking to outsource experiments with qualified service providers, Science Exchange makes it easier and more affordable for scientific institutions and researchers to access outsourced research and development services, ultimately accelerating the pace of scientific discovery.
Mon Ami
Seed Round in 2019
Mon Ami, Inc. is a California-based company founded in 2018 that has developed an application aimed at connecting college students with seniors who experience social isolation due to conditions such as dementia, Alzheimer’s, Parkinson’s disease, autism, and cancer. The platform facilitates meetings between seniors and companions or families, addressing the growing need for social connectivity among older adults. Additionally, Mon Ami offers software solutions tailored for aging and disability service providers, allowing them to enhance their operational efficiency and reduce administrative burdens. These tools are designed to be HIPAA compliant, enabling service providers to streamline workflows, increase their capacity to assist more seniors, and effectively track outcomes related to senior well-being. Through these initiatives, Mon Ami seeks to address challenges in the senior services market and improve the quality of life for older adults.
Heap
Series C in 2019
Heap Inc. is a company that develops an analytics infrastructure designed for online businesses, enabling them to capture and analyze customer interactions across web, mobile, and cloud platforms. Founded in 2012 and headquartered in San Francisco, California, Heap's solution automates the collection and organization of customer behavioral data, such as clicks, transactions, and form submissions, without requiring additional coding. This streamlined approach allows businesses to gain a comprehensive understanding of their users, facilitating informed decision-making and enhancing product development. Heap serves a diverse range of industries, including e-commerce, financial services, and SaaS, with over 6,000 clients that include notable companies across various sectors. The company is committed to empowering organizations to focus on insights and actions that drive business success.
Seer
Series C in 2019
Seer, Inc. is a life sciences company that specializes in nanoparticle technology solutions aimed at advancing proteomics research. The company offers Proteograph, an integrated system that includes consumables, automation instrumentation, and proprietary software for conducting proteomics analysis. Seer's products are designed for research applications, targeting academic institutions, life sciences laboratories, and biopharmaceutical companies for non-diagnostic and non-clinical uses. Additionally, Seer is focused on developing a health data platform that enhances early detection of chronic diseases by capturing and translating molecular insights from the proteome, thereby enabling healthcare professionals to identify conditions such as cancer and neurological disorders more accurately and rapidly. Founded in 2017 and headquartered in Redwood City, California, Seer was previously known as Seer Biosciences, Inc. before rebranding in July 2018.
1mg
Series D in 2019
1mg is a digital consumer healthcare platform based in Gurgaon, Haryana, India, that aims to make healthcare more accessible, understandable, and affordable. Launched in 2015, it allows users to find detailed information about medicines prescribed by doctors and purchase them directly. The platform enables users to search for drugs based on ailments, classes, companies, and brands. Additionally, 1mg offers a service that helps consumers find the right healthcare professionals tailored to their needs. Its diagnostics service enhances transparency and cost-effectiveness in lab tests, empowering Indian consumers and caregivers to choose appropriate healthcare services at competitive prices.
Aptible
Series A in 2019
Aptible Inc. is a security management platform based in San Francisco, California, that focuses on automating HIPAA compliance for web and mobile developers, particularly in the digital health sector. Founded in 2013, the company provides Aptible Enclave, a Docker-based solution for secure deployment within private AWS environments, and Aptible Gridiron, which offers a security management framework for cloud-based software engineering teams. The platform is designed as a service for startups and scaling companies, simplifying the complexities of provisioning, managing, and scaling infrastructure. By integrating essential features such as security, compliance inheritance, and reliability from the outset, Aptible allows developers to concentrate on product development without the burden of underlying infrastructure challenges.
Bounce
Series C in 2019
Bounce (formerly known as Metro Bikes) is a smart mobility solution, with a mission of making daily commute stress-free, time-saving, reliable, and convenient. With a breakthrough technology that lets users access the bike with just an OTP, the Keyless bikes, have not only done away with keys, but the whole process of renting a bike has just become devoid of any physical or human intervention. With Bounce's new One Way Rental service, users can now pick up and drop the bike anywhere they need to and be done with the ride. This is aimed at providing a seamless first mile and last-mile connectivity to metro users. Founded in 2014, Bounce aims at decongesting the roads by encouraging commuters to choose public transport by delivering convenient options to rent bikes and reach their destinations from metro stations. It is based in Bangalore, India.
Collective Health
Series E in 2019
Collective Health is a prominent health benefits platform that streamlines the management of medical, dental, vision, and pharmacy services for employees and their families. By offering an integrated solution through a cloud-based self-insurance platform, the company simplifies the administration of health plans via a single portal. This platform provides users with clear guidance, live concierge support, and digital tools to facilitate the navigation and management of healthcare services. Collective Health aims to reduce the complexities of delivering health benefits, enhance the member experience, and promote healthier outcomes for both employees and organizations. Headquartered in San Francisco, California, the company also has offices in Chicago, Illinois, and Lehi, Utah.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.